Participants sought: Tibolone for menopausal depression

 Two new clinical trials aim to discover the best treatment approach for the understudied depression that affects a large proportion of women in their late forties and fifties prior to, during or post menopause. These trials compare the effectiveness of a hormone treatment (Tibolone) for women with depression related to menopause, and that of standard antidepressant medication. Interested persons should contact Tamsyn Van Rheenen on 9076 5031 or Emmy Gavrilidis on 9076 6913 or visit www.maprc.org.au. For more about the study, see Monash story.